ÂÜÀòÂÒÂ×

Mari Scheiffele currently serves as President International at Ipsen since November 2021. Prior to this role, Mari held various leadership positions at Novartis, including General Manager for the UK & Ireland, where responsibilities encompassed Solid Tumors, Hematology, and Rare Therapies. In a previous capacity as Global Head of Strategy, Mari developed a 10-year oncology strategy and managed strategic projects and competitive intelligence. Mari also led the Ophthalmology and Specialty Care Business in Japan, overseeing a portfolio with P&L responsibility exceeding 700 million USD. Early career experience includes serving as Global Head of Pharma Strategy and Principal at McKinsey & Company, focusing on healthcare corporate finance and pharmaceutical launches. Mari holds a PhD in Biological and Biomedical Sciences from Harvard Medical School and an AB in Biochemical Sciences from Harvard University.